Researchers discover a potential target for immunotherapy-resistant prostate cancers
Researchers at the University of Notre Dame have identified how a gene called Pygo2 makes some prostate cancers resistant to treatment with immunotherapy.
Located in South Bend, Indiana, HCRI researchers are dedicated to conducting innovative and integrative research that confronts the complex challenges of cancer. From common malignancies to rare and recalcitrant cancers, researchers at the University of Notre Dame and Indiana University School of Medicine - South Bend are united in multi-disciplinary teams with a common goal: to increase the survival of all patients diagnosed with cancer.
University of Notre Dame and Indiana University School of Medicine, South Bend
Researchers at the University of Notre Dame have identified how a gene called Pygo2 makes some prostate cancers resistant to treatment with immunotherapy.